ORIC Pharmaceuticals Inc (NASDAQ:ORIC) price on Friday, July 25, fall -2.47% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $11.44.
A look at the stock’s price movement, the close in the last trading session was $11.73, moving within a range at $11.21 and $11.69. The beta value (5-Year monthly) was 1.531. Turning to its 52-week performance, $14.67 and $3.90 were the 52-week high and 52-week low respectively. Overall, ORIC moved 11.83% over the past month.
ORIC Pharmaceuticals Inc’s market cap currently stands at around $974.96 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Jun-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ORIC is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 5 recommend ORIC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ORIC’s current price about 4.51% and 24.07% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 63.57, while 7-day volatility ratio is 4.36% and 5.26% in the 30-day chart. Further, ORIC Pharmaceuticals Inc (ORIC) has a beta value of 1.70. Analysts have given the company’s stock an average 52-week price target of $12, forecast between a low of $12 and high of $12. Looking at the price targets, the low is -4.9% off current price level while to achieve the yearly target high, price needs to move -4.9%. Nonetheless, investors will most likely welcome a -4.9% jump to $12 which is the analysts’ median price.
If we refocus on ORIC Pharmaceuticals Inc (NASDAQ:ORIC), historical trading data shows that trading volumes averaged 0.51 over the past 10 days and 1.16 million over the past 3 months. The company’s latest data on shares outstanding shows there are 71.08 million shares.
The 50.31% of ORIC Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 69.95% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 12.29 million on 2025-07-15, giving us a short ratio of 13.15. The data shows that as of 2025-07-15 short interest in ORIC Pharmaceuticals Inc (ORIC) stood at 1463.0 of shares outstanding, with shares short falling to 12.71 million registered in 2025-06-13. Current price change has pushed the stock 1.60% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ORIC stock continues to rise going into the next quarter.
